GYRO

Gyrodyne, LLC - 10-Q Filing Summary (Q1 2026)

Business Context and Reporting Period

This Quarterly Report on Form 10-Q covers the period ended March 31, 2026. Gyrodyne, LLC is a limited liability company operating on a liquidation basis of accounting. The company's strategy focuses on pursuing entitlements for two remaining properties—Flowerfield (St. James, NY) and Cortlandt Manor (Cortlandt Manor, NY)—to maximize value before selling assets, settling debts, and distributing proceeds to shareholders. The estimated liquidation timeline is currently projected to conclude by December 31, 2028.

Key Financial Metrics

Note: The company does not report traditional revenue or profit margins due to the liquidation basis of accounting. Instead, it reports changes in net assets based on remeasurements of assets and liabilities.

Material Changes vs. Prior Period

• Net Asset Increase: Net assets increased by $65,005 (0.25%) primarily due to a favorable variance in actual expenses versus forecasted expenses for the quarter.
• Cash Position: Cash and cash equivalents decreased by approximately $579,370 from the prior quarter, reflecting operating costs, debt service, and entitlement expenditures.
• Liability Reduction: Total liabilities decreased by approximately $648,579, driven by a reduction in the estimated liquidation and operating costs liability.
• Debt Service: The company made principal payments on loans, reducing the total loans payable balance slightly.

Guidance, Outlook, and Risks

Outlook and Strategy:

• Flowerfield Sale: The company has a Purchase and Sale Agreement (B2K Agreement) for a 49-acre parcel of vacant land with a gross value estimated at $28,740,000. Closing is contingent on subdivision and site plan approvals. The company estimates closing could occur by October 2028, potentially extending to June 2029 if options are exercised.
• Entitlements: Subdivision approval for Flowerfield is targeted for Q3 2026, and Cortlandt Manor for 2027. The company anticipates incurring approximately $1.23 million in additional land entitlement costs through the end of 2028.
• Liquidity: Management believes current cash ($3.95 million) plus future rental income and asset sales will fund operations through 2028. However, the company may need to modify existing loan facilities or raise additional capital to ensure sufficient working capital.

• Article 78 Proceeding: A legal challenge regarding the Flowerfield subdivision approval is currently on appeal. While the Supreme Court dismissed the petition in October 2024, petitioners have appealed. The outcome could delay the sale timeline.
• Tenant Default: One of the three largest tenants (representing ~10% of rental income) is in default. Management is working to cure the default but notes potential risks of eviction and revenue loss.
• Regulatory Delays: Backlogs in land use applications and zoning authority labor shortages could extend the liquidation timeline beyond 2028.
• Market Conditions: High interest rates and inflation continue to impact commercial real estate valuations and the ability to secure financing.

Key Facts for Investor Verification

• Liquidation Timeline: Verify if the projected completion date of December 31, 2028, remains realistic given the ongoing Article 78 appeal and regulatory backlogs.
• B2K Transaction Status: Confirm the status of the subdivision and site plan approvals required to close the $28.74 million sale of the Flowerfield vacant land parcel.
• Tenant Default Resolution: Monitor the status of the defaulting tenant representing 10% of rental income to assess potential impact on cash flow.
• Capital Adequacy: Assess whether the current cash balance of $3.95 million is sufficient to cover the estimated $1.23 million in remaining entitlement costs and ongoing operating expenses without requiring dilutive capital raises or loan modifications.
• Legal Costs: Track the actual legal fees incurred for the Article 78 appeal against the estimated costs included in the liquidation liability.